HEDIS Results
Medicare Healthcare Effectiveness Data and Information Set (HEDIS®) Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
|
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
|
Breast Cancer Screening (BCS) |
66.04% |
71.00% |
|
|
|
Breast Cancer Screening (BCS-E) |
|
|
72.51% |
78.57% |
|
Care for Older Adults - Medication Review (COA) |
76.40% |
93.00% |
NQ |
87.00% |
|
Care for Older Adults - Pain Screening (COA) |
76.40% |
91.00% |
NQ |
90.00% |
|
Colorectal Cancer Screening (COL) |
55.47% |
71.00% |
62.29% |
77.86% |
|
Controlling Blood Pressure (CBP) |
65.45% |
74.00% |
67.88% |
80.65% |
|
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
|
|
66.42% |
77.68% |
|
Diabetes Care - Eye Exam (EED) |
51.82% |
73.00% |
55.72% |
81.03% |
|
Medication Reconciliation Post-Discharge (TRC) |
26.98% |
68.00% |
33.82% |
84.43% |
|
Osteoporosis Management in Women Who Had a Fracture (OMW) |
NA |
55.00% |
50.00% |
57.09% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
87.32% |
88.09% |
84.85% |
88.48% |
Every year, Medicare evaluates plans based on a 5-star rating system. For STAR ratings, please visit [Medicare Plan Finder or CMS.gov].
[MLI Taglines required on materials non-small sized only, therefore 8.5x11 paper output include all Multi-Languages taglines located here.]
NA = Not AvailableNQ = Not Required
H8176_25_8194_SCHCRates_C